Global Saliva Collection and Diagnostics Market Size Study, By Site of Collection (Parotid Gland Collection, Submandibular/Sublingual Gland Collection), By Application (Disease Diagnostics, Forensic Applications, Research), By End-Use (Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies), and Regional Forecasts, 2022–2032
The Global Saliva Collection and Diagnostics Market is poised for significant growth, with an estimated valuation of USD 0.78 Billion in 2023, projected to reach USD 1.18 Billion by 2032, growing at a CAGR of 4.7% during the forecast period. This surge is attributed to rising advancements in non-invasive diagnostic technologies, growing awareness about saliva-based testing, and innovations in sample collection devices.
The COVID-19 pandemic acted as a key accelerator, highlighting saliva's potential as a viable sample type for diagnostic applications, including infectious disease testing. The non-invasive nature of saliva collection methods, coupled with innovations like the SpeciMAX Stabilized Saliva Collection Kit, has further propelled market adoption. Moreover, the expansion of saliva-based diagnostics beyond COVID-19 into areas such as hormonal monitoring, stress analysis, and chronic disease detection underpins the increasing preference for this sample type over traditional blood tests.
Significant advancements in multiplex testing capabilities are streamlining the diagnostic process, enabling the simultaneous detection of multiple biomarkers from a single saliva sample. Applications in fields such as occupational health, sports medicine, and oncology are further bolstering the market's prospects.
Regionally, North America dominated in 2024 with a revenue share of 48.71%, driven by an increase in infectious disease cases and advancements in testing technology. In Europe, the market benefits from a robust healthcare infrastructure and rising regional players introducing innovative solutions. Meanwhile, the Asia Pacific region is witnessing the fastest growth, driven by increasing adoption of non-invasive testing methods.
________________________________________
Major market players included in this report are:
The detailed segments and sub-segments of the market are explained below:
By Site of Collection:
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032
Key Takeaways:
The COVID-19 pandemic acted as a key accelerator, highlighting saliva's potential as a viable sample type for diagnostic applications, including infectious disease testing. The non-invasive nature of saliva collection methods, coupled with innovations like the SpeciMAX Stabilized Saliva Collection Kit, has further propelled market adoption. Moreover, the expansion of saliva-based diagnostics beyond COVID-19 into areas such as hormonal monitoring, stress analysis, and chronic disease detection underpins the increasing preference for this sample type over traditional blood tests.
Significant advancements in multiplex testing capabilities are streamlining the diagnostic process, enabling the simultaneous detection of multiple biomarkers from a single saliva sample. Applications in fields such as occupational health, sports medicine, and oncology are further bolstering the market's prospects.
Regionally, North America dominated in 2024 with a revenue share of 48.71%, driven by an increase in infectious disease cases and advancements in testing technology. In Europe, the market benefits from a robust healthcare infrastructure and rising regional players introducing innovative solutions. Meanwhile, the Asia Pacific region is witnessing the fastest growth, driven by increasing adoption of non-invasive testing methods.
________________________________________
Major market players included in this report are:
- Thermo Fisher Scientific, Inc.
- Neogen Corporation
- Abbott
- Sarstedt AG & Co.KG
- Autogen, Inc.
- Oasis Diagnostics
- Porex
- Salimetrics, LLC
- Takara Bio, Inc.
- Arcis Bio
- Orasure Technologies
- Nusantics Group
- Mark Microbiotech
- Bio Farma
- Salignostics
The detailed segments and sub-segments of the market are explained below:
By Site of Collection:
- Parotid Gland Collection
- Submandibular/Sublingual Gland Collection
- Others
- Disease Diagnostics
- Forensic Applications
- Research
- Diagnostic Laboratories
- Pharmaceutical & Biotechnology Companies
- Research Institutes
- Dentistry
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Thailand
- Latin America
- Brazil
- Argentina
- Middle East & Africa
- Saudi Arabia
- South Africa
- UAE
- Kuwait
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032
Key Takeaways:
- Market Estimates & Forecasts for 10 years (2022–2032).
- Annualized revenues and regional-level analysis for each market segment.
- Competitive landscape analysis with company profiles of major players.
- Strategic insights on emerging market trends and opportunities.
CHAPTER 1: GLOBAL SALIVA COLLECTION AND DIAGNOSTICS MARKET EXECUTIVE SUMMARY
1.1. Global Market Size & Forecast (2022–2032)
1.2. Regional Overview
1.3. Segmental Analysis
1.3.1. By Site of Collection
1.3.2. By Application
1.3.3. By End-Use
1.4. Key Market Trends
1.5. Recession Impact Analysis
1.6. Analyst Recommendations
________________________________________
CHAPTER 2: MARKET DEFINITION AND RESEARCH ASSUMPTIONS
2.1. Research Objectives
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion Criteria
2.3.2. Limitations
2.3.3. Supply-Side Analysis
2.3.4. Demand-Side Analysis
2.4. Estimation Methodology
2.5. Years Considered for the Study
________________________________________
CHAPTER 3: MARKET DYNAMICS
3.1. Market Drivers
3.1.1. Increasing Adoption of Non-Invasive Diagnostic Techniques
3.1.2. Technological Advancements in Sample Collection
3.1.3. Expanding Applications of Saliva-Based Diagnostics
3.2. Market Challenges
3.2.1. Regulatory Barriers in Emerging Markets
3.2.2. Challenges in Sample Stability and Integrity
3.3. Market Opportunities
3.3.1. Growth in Multiplex Testing Capabilities
3.3.2. Rising Investment in R&D
________________________________________
CHAPTER 4: INDUSTRY ANALYSIS
4.1. Porter’s Five Forces Analysis
4.2. PESTEL Analysis
4.3. Disruptive Trends in Diagnostics
4.4. Key Investment Opportunities
4.5. Expert Recommendations
________________________________________
CHAPTER 5: GLOBAL MARKET SIZE AND FORECAST BY SITE OF COLLECTION (2022–2032)
5.1. Parotid Gland Collection
5.2. Submandibular/Sublingual Gland Collection
5.3. Others
________________________________________
CHAPTER 6: GLOBAL MARKET SIZE AND FORECAST BY APPLICATION (2022–2032)
6.1. Disease Diagnostics
6.2. Forensic Applications
6.3. Research
________________________________________
CHAPTER 7: GLOBAL MARKET SIZE AND FORECAST BY END-USE (2022–2032)
7.1. Diagnostic Laboratories
7.2. Pharmaceutical & Biotechnology Companies
7.3. Research Institutes
7.4. Dentistry
________________________________________
CHAPTER 8: REGIONAL ANALYSIS (2022–2032)
8.1. North America
8.2. Europe
8.3. Asia Pacific
8.4. Latin America
8.5. Middle East & Africa
________________________________________
CHAPTER 9: COMPETITIVE INTELLIGENCE
9.1. Key Company SWOT Analysis
9.1.1. Thermo Fisher Scientific, Inc.
9.1.2. Neogen Corporation
9.1.3. Abbott
9.2. Strategic Developments
9.3. Market Share Analysis
________________________________________
CHAPTER 10: RESEARCH PROCESS
10.1. Data Collection Techniques
10.2. Market Estimation Methods
10.3. Validation Process
12. LIST OF TABLES
• TABLE 1: Global Saliva Collection Market Estimates by Site of Collection (2025–2030)
• TABLE 2: Market Forecasts by Application (2025–2030)
• TABLE 3: End-Use Market Revenue Trends
12. LIST OF FIGURES
• FIGURE 1: Global Market Size Overview (2025–2030)
• FIGURE 2: Market Share by Application, 2024
• FIGURE 3: Growth Opportunities in Regional Markets
This list is not complete; the final report includes over 100 tables and 50 figures.
1.1. Global Market Size & Forecast (2022–2032)
1.2. Regional Overview
1.3. Segmental Analysis
1.3.1. By Site of Collection
1.3.2. By Application
1.3.3. By End-Use
1.4. Key Market Trends
1.5. Recession Impact Analysis
1.6. Analyst Recommendations
________________________________________
CHAPTER 2: MARKET DEFINITION AND RESEARCH ASSUMPTIONS
2.1. Research Objectives
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion Criteria
2.3.2. Limitations
2.3.3. Supply-Side Analysis
2.3.4. Demand-Side Analysis
2.4. Estimation Methodology
2.5. Years Considered for the Study
________________________________________
CHAPTER 3: MARKET DYNAMICS
3.1. Market Drivers
3.1.1. Increasing Adoption of Non-Invasive Diagnostic Techniques
3.1.2. Technological Advancements in Sample Collection
3.1.3. Expanding Applications of Saliva-Based Diagnostics
3.2. Market Challenges
3.2.1. Regulatory Barriers in Emerging Markets
3.2.2. Challenges in Sample Stability and Integrity
3.3. Market Opportunities
3.3.1. Growth in Multiplex Testing Capabilities
3.3.2. Rising Investment in R&D
________________________________________
CHAPTER 4: INDUSTRY ANALYSIS
4.1. Porter’s Five Forces Analysis
4.2. PESTEL Analysis
4.3. Disruptive Trends in Diagnostics
4.4. Key Investment Opportunities
4.5. Expert Recommendations
________________________________________
CHAPTER 5: GLOBAL MARKET SIZE AND FORECAST BY SITE OF COLLECTION (2022–2032)
5.1. Parotid Gland Collection
5.2. Submandibular/Sublingual Gland Collection
5.3. Others
________________________________________
CHAPTER 6: GLOBAL MARKET SIZE AND FORECAST BY APPLICATION (2022–2032)
6.1. Disease Diagnostics
6.2. Forensic Applications
6.3. Research
________________________________________
CHAPTER 7: GLOBAL MARKET SIZE AND FORECAST BY END-USE (2022–2032)
7.1. Diagnostic Laboratories
7.2. Pharmaceutical & Biotechnology Companies
7.3. Research Institutes
7.4. Dentistry
________________________________________
CHAPTER 8: REGIONAL ANALYSIS (2022–2032)
8.1. North America
8.2. Europe
8.3. Asia Pacific
8.4. Latin America
8.5. Middle East & Africa
________________________________________
CHAPTER 9: COMPETITIVE INTELLIGENCE
9.1. Key Company SWOT Analysis
9.1.1. Thermo Fisher Scientific, Inc.
9.1.2. Neogen Corporation
9.1.3. Abbott
9.2. Strategic Developments
9.3. Market Share Analysis
________________________________________
CHAPTER 10: RESEARCH PROCESS
10.1. Data Collection Techniques
10.2. Market Estimation Methods
10.3. Validation Process
12. LIST OF TABLES
• TABLE 1: Global Saliva Collection Market Estimates by Site of Collection (2025–2030)
• TABLE 2: Market Forecasts by Application (2025–2030)
• TABLE 3: End-Use Market Revenue Trends
12. LIST OF FIGURES
• FIGURE 1: Global Market Size Overview (2025–2030)
• FIGURE 2: Market Share by Application, 2024
• FIGURE 3: Growth Opportunities in Regional Markets
This list is not complete; the final report includes over 100 tables and 50 figures.
